Copyright 2006 American Medical Association. All Rights Reserved. Applicable FARS/DFARS Restrictions Apply to Government Use.2006
University of Michigan, Ann Arbor;
University of Rochester, Rochester, NY
Objective: To assess tumor markers in advanced laryngeal cancer.
Design: Marker expression and clinical outcome.
Patients: Tissues from 112 patients of the Veterans Affairs laryngeal cancer trial were analyzed: 42 from the chemotherapy arm and 70 from the surgical arm of the study.
Kumar B, Cordell KG, D'Silva N, et al. S024 Expression of p53 and Bcl-xL as Predictive Markers for Larynx Preservation in Advanced Laryngeal Cancer. Arch Otolaryngol Head Neck Surg. 2006;132(8):843–844. doi:10.1001/archotol.132.8.843-c
Customize your JAMA Network experience by selecting one or more topics from the list below.